Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone and Ticagrelor in CAD patients receiving Morphine
NCT02403830Phase 4Completed
- Sponsor
- University of Florida
- Start
- Aug 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylnaltrexone in coronary artery disease (CAD), sponsored by University of Florida. Started Aug 2015; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02403830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403830.